Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin

Journal of Urology

Volumn 182, Issue 4 SUPPL., 2009, Pages 1313-1317

  Nativ, Ofer ^a   Witjes, J Alfred ^f   Hendricksen, Kees ^f   Cohen, Michael ^b   Kedar, Daniel ^c   Sidi, Ami ^d   Colombo, Renzo ^g   Leibovitch, Ilan ^e  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e MEIR MEDICAL CENTER   (Israel)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

carcinoma; drug therapy; hyperthermia; induced; Mycobacterium bovis; urinary bladder

Indexed keywords

BCG VACCINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CATHETER COMPLICATION; CYSTOSCOPY; CYTOPATHOLOGY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSURIA; FEMALE; HEMATURIA; HUMAN; HYPERTHERMIC THERAPY; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE SPASM; NOCTURIA; PAIN; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; URETHRA STENOSIS; URETHRA STRICTURE; URINARY TRACT INFECTION; UROGENITAL TRACT CANCER; UROTHELIAL CELL CANCER; UROTHELIAL CELL CARCINOMA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BCG VACCINE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 69749111213     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.06.017     Document Type: Article

References (21)

1. Nadler R.B., Catalona W.J., Hudson M.A., et al. Durability of the tumor-free response for intravesical bacillus Calmette-Guérin therapy. J Urol 152 (1994) 367
2. Lamm D.L., Blumenstein B.A., Crawford E.D., et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med 325 (1991) 1205
3. Joudi F.N., Smith B.J., and O'Donnell M.A. Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer. Urol Oncol 24 (2006) 344
4. Witjes J.A. Management of BCG failures in superficial bladder cancer: a review. Eur Urol 49 (2006) 790
5. Colombo R., Da Pozzo L.F., Salonia A., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21 (2003) 4270
6. Van DerHeijden A.G., Kiemeney L.A., Gofrit O.N., et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 46 (2004) 65
7. Gofrit O.N., Shapiro A., Pode D., et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 63 (2004) 466
8. O'Donnell M.A., and Boehle A. Treatment options for BCG failures. World J Urol 24 (2006) 481
9. Leblanc B., Duclos A.J., Bénard F., et al. Long term follow-up of intravesical bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma. Can J Urol 7 (2000) 944
10. Lamm D.L., Blumenstein B.A., Crissman J.D., et al. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163 (2000) 1124
11. Madersbacher S., Möhrle K., Burkhard F., et al. Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol 167 (2002) 2052
12. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
13. Catalona W.J., Hudson M.A., Gillen D.P., et al. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. J Urol 137 (1987) 220
14. Malmstrom P.U., Wijkstrom H., Lundholm C., et al. 5-Year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guérin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group. J Urol 161 (1999) 1124
15. Dalbagni G., Russo P., Bochner B., et al. Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. J Clin Oncol 24 (2006) 2729
16. Herman T.S., Teicher B.A., Jochelson M., et al. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hypertherm 4 (1988) 143
17. Paroni R., Salonia A., Lev A., et al. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 52 (2001) 273
18. van der Heijden A.G., Hulsbergen-Van de Kaa C.A., and Witjes J.A. The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis. World J Urol 25 (2007) 303
19. Andius P., and Holmäng S. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int 93 (2004) 980
20. Lamm D.L., Blumenstein B.A., Crissman J.D., et al. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163 (2000) 1124
21. Huguet J., Crego M., Sabaté S., et al. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 48 (2005) 53